[1]
N. Denaro, “Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review”, EJCRIM, vol. 8, no. 6, Jun. 2021.